Share on :

Asset Summary

Daily Performance Report for ABBV ETF: Dec 23, 2024

Summary: The day started with ABBV ETF opening at $175.59 and closing at $175.32. The ETF showed weakness throughout the day, with the highest price observed at $175.59 and the lowest at $174.5. The underlying asset had a trading range of $1.09 Overall, it was a negative trading day for ABBV ETF, reflecting investor pessimism and market activity.

Change in Closing Price: There was a net decrease of $-0.27 or -0.15% in the closing price from the opening to the closing price over the day.

Volume Analysis: Trading volume for ABBV ETF was 4,413 units during Dec 23, 2024, indicating active market participation and investor interest.

Opening Price: The day started at $175.59.

Highest Price: The highest price observed during the day was $175.59.

Lowest Price: The lowest price observed during the day was $174.5.

Closing Price: The day ended at $175.32.

Asset Performance Metrics and Risk Characteristics:

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. By using various technical indicators and chart patterns, investors can gain insights into market trends, price momentum, and potential turning points. This section delves into essential technical metrics, including moving averages, pivot points, and other indicators that provide a snapshot of an asset's current technical stance. Analyzing these indicators helps investors identify entry and exit points, assess market sentiment, and refine their trading strategies. Explore the following technical analysis data to understand the asset's performance dynamics and make better-informed decisions.

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Unlock Your ABBV Trading Now

Transform your approach to trading with RankMyTrade.com. Our automated system offers detailed metrics and technical analysis for ABBV, tailored to enhance your trading performance. Start optimizing your trades today and elevate your strategy today!

Explore Insights Now

Frequently Asked Questions

ABBV does not undergo traditional rebalancing like an ETF, but it regularly assesses its product pipeline and strategic initiatives to optimize performance.

ABBV is managed through various therapeutic areas, including immunology, oncology, neuroscience, and virology, with a strong emphasis on research and development.

Dividends paid by ABBV can be reinvested to purchase additional shares or received in cash, depending on the investor’s preference.

ABBV offers a range of pharmaceuticals, including treatments for immunological conditions, oncology therapies, and neuroscience-related medications.

ABBV’s performance can be compared to other biopharmaceutical companies, focusing on product pipeline success, market share, and revenue growth.

Key metrics include revenue growth, earnings per share (EPS), net income, and return on equity (ROE), which indicate the company’s financial health.

Yes, ABBV can be held in retirement accounts such as IRAs or 401(k)s, making it a suitable choice for long-term investment strategies.

As of the latest update, ABBV has a dividend yield of approximately 4.4%, reflecting its commitment to returning value to shareholders.

Similar companies include Pfizer, Merck, and Johnson & Johnson, which also focus on pharmaceuticals and biopharmaceuticals.

Investors can purchase shares of ABBV through a brokerage account, as it is publicly traded on the New York Stock Exchange (NYSE) under the ticker symbol "ABBV."

Unlock Your ABBV Trading Now

Discover unparalleled trading insights with Rank My Trade. Our automated system offers advanced analysis and technical indicators for ABBV, aimed at optimizing your trading decisions. Transform your trading strategy now and get ahead in the market now!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. RankMyTrade (RMT) has not independently verified this data and does not guarantee its accuracy. The information and calculations provided by RankMyTrade are for educational and informational purposes only and should not be construed as financial or investment advice.

With any investment, your capital is at risk. The value of your portfolio go down as well as up. Past performance is no guarantee of future results. By using this website, you accept our Terms of Service, Privacy Policy, and Payment Agreement.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind. Unless otherwise noted, RankMyTrade and its affiliates are not partners, affiliates, or licensees of these companies.

Supported Assets & ETFs